245 related articles for article (PubMed ID: 34812852)
21. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
[TBL] [Abstract][Full Text] [Related]
22. Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury.
Izushi Y; Teshigawara K; Liu K; Wang D; Wake H; Takata K; Yoshino T; Takahashi HK; Mori S; Nishibori M
J Pharmacol Sci; 2016 Apr; 130(4):226-34. PubMed ID: 27038888
[TBL] [Abstract][Full Text] [Related]
23. Soluble Receptor for Advanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways.
Wu X; Gu W; Lu H; Liu C; Yu B; Xu H; Tang Y; Li S; Zhou J; Shao C
Oxid Med Cell Longev; 2016; 2016():1015390. PubMed ID: 27688824
[TBL] [Abstract][Full Text] [Related]
24. RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.
Shang L; Ananthakrishnan R; Li Q; Quadri N; Abdillahi M; Zhu Z; Qu W; Rosario R; Touré F; Yan SF; Schmidt AM; Ramasamy R
PLoS One; 2010 Apr; 5(4):e10092. PubMed ID: 20404919
[TBL] [Abstract][Full Text] [Related]
25. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
Prasad K
Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
[TBL] [Abstract][Full Text] [Related]
26. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
27. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H
Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773
[TBL] [Abstract][Full Text] [Related]
28. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
29. Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis.
Kim CH; Kang HY; Kim G; Park J; Nam BY; Park JT; Han SH; Kang SW; Yoo TH
Front Pharmacol; 2023; 14():1172269. PubMed ID: 37261287
[No Abstract] [Full Text] [Related]
30. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
[TBL] [Abstract][Full Text] [Related]
31. Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
Malik P; Hoidal JR; Mukherjee TK
COPD; 2021 Dec; 18(6):737-748. PubMed ID: 34615424
[TBL] [Abstract][Full Text] [Related]
32. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
[TBL] [Abstract][Full Text] [Related]
33. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging.
Scavello F; Zeni F; Tedesco CC; Mensà E; Veglia F; Procopio AD; Bonfigli AR; Olivieri F; Raucci A
Aging (Albany NY); 2019 Mar; 11(6):1648-1663. PubMed ID: 30903794
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of gastrointestinal RAGE (receptor for advanced glycation end products) expression in dogs with chronic inflammatory enteropathy.
Cabrera-García AI; Protschka M; Alber G; Kather S; Dengler F; Müller U; Steiner JM; Heilmann RM
Vet Immunol Immunopathol; 2021 Apr; 234():110216. PubMed ID: 33636544
[TBL] [Abstract][Full Text] [Related]
35. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.
Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563
[TBL] [Abstract][Full Text] [Related]
36. The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome.
Steenbeke M; De Bruyne S; De Buyzere M; Lapauw B; Speeckaert R; Petrovic M; Delanghe JR; Speeckaert MM
Crit Rev Clin Lab Sci; 2021 Mar; 58(2):113-130. PubMed ID: 32669010
[TBL] [Abstract][Full Text] [Related]
37. The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries.
Salehi M; Amiri S; Ilghari D; Hasham LFA; Piri H
Indian J Clin Biochem; 2023 Apr; 38(2):159-171. PubMed ID: 35999871
[TBL] [Abstract][Full Text] [Related]
38. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
39. HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury.
Mi L; Zhang Y; Xu Y; Zheng X; Zhang X; Wang Z; Xue M; Jin X
Biomed Pharmacother; 2019 Aug; 116():109005. PubMed ID: 31136947
[TBL] [Abstract][Full Text] [Related]
40. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
